Description: Sysmex Corporation, together with its subsidiaries, engages in the development, manufacture, sale, and export/import of diagnostic instruments, reagents, and related software for the use in hematology, urinalysis, immunochemistry, clinical chemistry, and hemostasis. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; systems for high-volume testing in labs; and hematology analyzers for animals. The company also provides urine formed sediment analysis systems; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for to test for liver fibrosis progression and atopic dermatitis; and support services for hemostasis products. In addition, it offers systems for the detection of cancer lymph node metastasis; cytogenic testing services; and lab assay services. It serves national and other public hospitals, private hospitals, universities, research institutes, other medical institutions, etc. The company operates in the Americas, Europe, the Middle East, Africa, the Asia Pacific, China, and Japan. Sysmex Corporation has collaboration with MolecularMD Corporation to develop and commercialize companion diagnostics. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.
Home Page: www.sysmex.co.jp
1-5-1 Wakinohama-kaigandori
Kobe,
651-0073
Japan
Phone:
81 78 265 0500
Officers
| Name | Title |
|---|---|
| Mr. Hisashi Ietsugu | Chairman of the Managing Board & CEO |
| Mr. Kaoru Asano | CTO, Sr. MD, Sr. Exec. Officer, Sr. MD & Member of the Managing Board |
| Mr. Iwane Matsui | MD of Global Marketing, Sr. Exec. Officer & Member of Managing Board |
| Mr. Kenji Tachibana | Sr. MD of Corp Mgmt & Regulatory Affairs, Sr. Exec. Officer & Member of the Managing Board |
| Mr. Hiroshi Kanda | MD of Bus. Strategy Devel., Sr. Exec. Officer & Member of the Managing Board |
| Mr. Mamoru Kubota | Sr. Exec. Officer & Deputy in charge of Bus. Strategy Devel. |
| Mr. Kensuke Lizuka | Sr. Exec. Officer & Exec. VP of Corp. Bus. Planning Div. |
| Mr. Tomokazu Yoshida | Sr. Exec. Officer, MD of R&D, Incubation & MR Bus. and Member of the Managing Board |
| Mr. Takashi Ono | Sr. Exec. Officer |
| Mr. Mitsuhisa Kanagawa | Exec. Officer of IVD Bus. Unit & Exec. VP of Bus. Strategy Devel. |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| Forward PE: | 35.2113 |
|---|---|
| Trailing PE: | 35.4551 |
| Price-to-Book MRQ: | 4.7425 |
| Price-to-Sales TTM: | 0.0354 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 8771 |